GO:0070381 endosome to plasma membrane transport vesicle: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0070381 describes a transport vesicle that mediates transport from the endosome to the plasma membrane and fuses with the plasma membrane to deliver lipids and membrane proteins and to release cargo by exocytosis.
• Formation of this vesicle depends on endosomal membrane remodeling, including ESCRT-mediated budding and phosphoinositide signaling [1, 2, 8].
• Cargo selection and vesicle identity involve tetraspanins such as CD63 and CD9, which are tracked in live cells to distinguish exosome versus ectosome secretion.
• Biomolecular condensates can mediate bending and scission of endosome membranes, a newly recognized mechanism in vesicle biogenesis.
• Retromer-dependent receptor recycling intersects with endosome-to-plasma membrane transport, influencing cargo return and signaling.
• Dysregulation of this vesicle pathway is linked to cancer, neurodegeneration, and infectious disease, making it a target for CRISPR-based functional studies [1, 6, 7].
Description
The endosome to plasma membrane transport vesicle (GO:0070381) is a cellular component defined as a transport vesicle that mediates transport from the endosome to the plasma membrane and fuses with the plasma membrane to deliver lipids and membrane proteins and to release cargo molecules by exocytosis. This vesicle is central to the constitutive secretory pathway and to the recycling of membrane proteins, and its dysfunction is implicated in a range of diseases [1, 7]. Understanding its formation, cargo selection, and fusion is essential for cell biology and for therapeutic development.
endosome to plasma membrane transport vesicle At A Glance
| GO ID | GO:0070381 |
|---|---|
| GO term | endosome to plasma membrane transport vesicle |
| Ontology | cellular_component |
| Synonym | endosome-plasma membrane transport vesicle; endosome to plasma membrane constitutive secretory pathway transport vesicle |
| Major function | Mediates transport from the endosome to the plasma membrane and fuses with the plasma membrane to deliver lipids and membrane proteins and to release cargo by exocytosis |
| Related process | Constitutive secretory pathway, receptor recycling, exosome secretion |
| Key regulators | ESCRT complexes, phosphoinositides, tetraspanins, retromer |
| Disease relevance | Cancer, neurodegeneration, infectious disease |
What Is GO:0070381?
GO:0070381 refers to a transport vesicle that carries material from the endosome to the plasma membrane. It fuses with the plasma membrane to deliver lipids and membrane proteins and to release various cargo molecules, such as proteins or hormones, by exocytosis. This term is a cellular component and is also known as the endosome-plasma membrane transport vesicle or the endosome to plasma membrane constitutive secretory pathway transport vesicle.
Why Is endosome to plasma membrane transport vesicle Important in Cell Biology?
The endosome to plasma membrane transport vesicle is essential for maintaining plasma membrane composition and for releasing signaling molecules and cargo. Its dysfunction contributes to cancer progression, neurodegeneration, and infectious disease, and it is a key node for understanding exosome biology and retromer-mediated recycling [1, 6, 7].
• Controls delivery of lipids and membrane proteins to the plasma membrane.
• Mediates exocytosis of proteins and hormones.
• Involved in exosome secretion and intercellular communication [2, 4].
• Regulates receptor recycling via retromer.
• Implicated in cancer through altered secretion and signaling.
• Linked to neurodegeneration via defective endosomal trafficking.
• Exploited by viruses for budding and release.
• Target for CRISPR screens to identify novel regulators [1, 5].
• Requires phosphoinositide signaling for membrane identity.
• Can be studied with live-cell imaging of CD63 and CD9.
What Happens During endosome to plasma membrane transport vesicle?
Vesicle Budding from Endosomes
In simple terms: The vesicle forms by pinching off from the endosome membrane.
Budding of transport vesicles from endosomes requires membrane deformation and scission. ESCRT complexes mediate budding of exosome vesicles into multivesicular endosomes [1, 2]. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Biomolecular condensates can mediate bending and scission of endosome membranes.
Cargo Selection and Sorting
In simple terms: Specific proteins and lipids are selected to go into the vesicle.
Cargo selection involves tetraspanins such as CD63 and CD9, which are tracked in live cells to distinguish exosome versus small ectosome secretion. Retromer mediates receptor recycling by sorting cargo from endosomes back to the plasma membrane.
Vesicle Transport and Fusion
In simple terms: The vesicle moves to the plasma membrane and merges with it.
The vesicle fuses with the plasma membrane to deliver lipids and membrane proteins and to release cargo molecules by exocytosis. This process is part of the constitutive secretory pathway and requires phosphoinositide signaling for membrane identity.
Key Genes Involved in GO:0070381 endosome to plasma membrane transport vesicle
Key genes and proteins involved in endosome to plasma membrane transport vesicle include ESCRT components, tetraspanins, retromer subunits, and phosphoinositide regulators.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TSG101 | ESCRT-I component, mediates budding | Knockout reduces exosome secretion |
| CHMP4B | ESCRT-III component, membrane scission | Point mutations affect vesicle formation |
| CD63 | Tetraspanin, cargo marker | Live tracking of exosome vs ectosome |
| CD9 | Tetraspanin, cargo marker | Live tracking of exosome vs ectosome |
| VPS35 | Retromer subunit, receptor recycling | Knockout impairs recycling |
| VPS26 | Retromer subunit | Knockout impairs recycling |
| VPS29 | Retromer subunit | Knockout impairs recycling |
| SNX1 | Retromer-associated sorting nexin | Knockout affects endosomal sorting |
| SNX2 | Retromer-associated sorting nexin | Knockout affects endosomal sorting |
| PIK3C3 | Phosphoinositide kinase, endosomal identity | Knockout alters phosphoinositides |
| PIK3R4 | Phosphoinositide kinase subunit | Knockout alters phosphoinositides |
| RAB7A | Late endosome marker, transport | Knockout affects vesicle transport |
| RAB11A | Recycling endosome marker | Knockout affects recycling |
| RAB27A | Exosome secretion regulator | Knockout reduces exosome release |
| RAB27B | Exosome secretion regulator | Knockout reduces exosome release |
| SDC1 | Syndecan, cargo | Knockout affects exosome cargo |
| SDC4 | Syndecan, cargo | Knockout affects exosome cargo |
How Is endosome to plasma membrane transport vesicle Regulated?
Regulation of endosome to plasma membrane transport vesicle involves phosphoinositide signaling, which controls membrane identity and recruitment of effector proteins. ESCRT complexes are regulated by their assembly and disassembly, and their dysfunction leads to impaired vesicle formation. Retromer-mediated recycling is regulated by cargo selection and membrane recruitment. Additionally, biomolecular condensates can regulate membrane bending and scission.
endosome to plasma membrane transport vesicle and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| VPS35 | Neurodegeneration | Knockout in neurons |
| TSG101 | Cancer | Knockout in cancer cell lines |
| CD63 | Cancer | Knock-in with fluorescent tag |
| CHMP4B | Infectious disease | Point mutation in viral budding assays |
| RAB27A | Cancer | Overexpression in melanoma cells |
Cancer
Altered endosome to plasma membrane transport vesicle function contributes to cancer through changes in secretion of growth factors and receptors. ESCRT components are frequently dysregulated in cancers, affecting exosome secretion and intercellular communication.
Neurodegeneration
Defective retromer-mediated receptor recycling is linked to neurodegenerative diseases such as Alzheimer's disease. Mutations in retromer subunits impair endosome-to-plasma membrane transport, leading to neuronal dysfunction.
Infectious Disease
Many enveloped viruses exploit ESCRT-mediated budding to release viral particles. The endosome to plasma membrane transport vesicle pathway is hijacked by retroviruses for budding and release.
From endosome to plasma membrane transport vesicle-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate vesicle budding? | Knockout cell line |
| Does mutation Y affect cargo sorting? | Point mutation knock-in |
| Where does protein Z localize? | Tagged knock-in |
| Does overexpression of gene W increase secretion? | Overexpression cell line |
| Which genes are essential for vesicle transport? | CRISPR library screening |
| How does condensate formation affect scission? | Knock-in of condensate markers |
How to Study the endosome to plasma membrane transport vesicle Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Live-cell imaging | Vesicle tracking and fusion | CD63/CD9 secretion |
| Proteomics | Cargo and protein composition | Vesicle isolation |
| CRISPR screening | Gene essentiality | Regulator discovery |
| Electron microscopy | Ultrastructure | Budding and scission |
| Phosphoinositide analysis | Lipid composition | Membrane identity |
| Retromer recycling assay | Receptor recycling | VPS35 function |
| Exosome secretion assay | Vesicle release | RAB27A function |
Live-Cell Imaging
Live intracellular tracking of CD63 and CD9 reveals specificities of exosome versus small ectosome secretion.
Proteomics
Proteomic analysis of isolated vesicles identifies cargo and regulators of endosome to plasma membrane transport.
CRISPR Screening
Genome-wide CRISPR screens identify genes required for vesicle formation and secretion.
Electron Microscopy
Electron microscopy visualizes vesicle budding and membrane scission events.
How CRISPR Can Be Used to Study GO:0070381 endosome to plasma membrane transport vesicle
Knockout
CRISPR knockout of ESCRT components such as TSG101 reduces exosome secretion and impairs endosome to plasma membrane transport.
Point Mutation
Point mutations in CHMP4B can disrupt ESCRT-III function and vesicle scission, providing models for studying membrane remodeling.
Knock-in
Knock-in of fluorescent tags on CD63 or CD9 allows live tracking of vesicle trafficking and secretion.
Overexpression
Overexpression of RAB27A or RAB27B increases exosome release, enabling studies of secretion regulation.
How EDITGENE Supports endosome to plasma membrane transport vesicle Research
Researchers studying endosome to plasma membrane transport vesicle-related genes often need to determine whether a candidate gene is causally involved in vesicle formation, cargo sorting, or fusion. EDITGENE provides CRISPR-based services to create knockout, point mutation, knock-in, and overexpression cell models, as well as library screening and bioinformatics support.
Contact EDITGENE today to design your custom CRISPR model for endosome to plasma membrane transport vesicle research.
Frequently Asked Questions About endosome to plasma membrane transport vesicle
What is GO:0070381?
GO:0070381 is the Gene Ontology term for endosome to plasma membrane transport vesicle, a cellular component that mediates transport from the endosome to the plasma membrane and fuses with the plasma membrane to deliver lipids and membrane proteins and to release cargo by exocytosis.
What genes are involved in endosome to plasma membrane transport vesicle?
Key genes include ESCRT components such as TSG101 and CHMP4B, tetraspanins CD63 and CD9, retromer subunits VPS35, VPS26, and VPS29, and phosphoinositide regulators PIK3C3 and PIK3R4 [1, 4, 7, 8].
How is endosome to plasma membrane transport vesicle regulated?
It is regulated by phosphoinositide signaling, ESCRT assembly, retromer-mediated cargo selection, and biomolecular condensates [1, 5, 7, 8].
What diseases are linked to endosome to plasma membrane transport vesicle?
Dysregulation is linked to cancer, neurodegeneration, and infectious disease [1, 6, 7].
What methods study endosome to plasma membrane transport vesicle?
Live-cell imaging, proteomics, CRISPR screening, and electron microscopy are commonly used [1, 4, 5].
What is the role of ESCRT in this vesicle?
ESCRT complexes mediate budding and scission of vesicles from endosomes.
How does retromer relate to this vesicle?
Retromer mediates receptor recycling from endosomes to the plasma membrane, intersecting with this transport pathway.
Can CRISPR be used to study this vesicle?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are used to dissect gene function [1, 4].
What is the difference between exosome and ectosome secretion?
Live tracking of CD63 and CD9 reveals specificities of exosome versus small ectosome secretion.
What is the clinical relevance of this vesicle?
It is relevant for cancer therapy, neurodegenerative disease, and antiviral strategies [1, 6, 7].
Conclusion
The endosome to plasma membrane transport vesicle (GO:0070381) is a critical cellular component for delivering lipids, membrane proteins, and cargo to the plasma membrane. Its formation and function involve ESCRT complexes, tetraspanins, retromer, and phosphoinositide signaling, and its dysfunction is linked to cancer, neurodegeneration, and infectious disease. CRISPR-based models and screening approaches provide powerful tools to dissect this pathway and identify therapeutic targets.
References
- 1. Vietri M et al.. 2020. The many functions of ESCRTs.. Nat Rev Mol Cell Biol 21(1):25-42 PMID: 31705132
- 2. Trajkovic K et al.. 2008. Ceramide triggers budding of exosome vesicles into multivesicular endosomes.. Science 319(5867):1244-7 PMID: 18309083
- 4. Mathieu M et al.. 2021. Specificities of exosome versus small ectosome secretion revealed by live intracellular tracking of CD63 and CD9.. Nat Commun 12(1):4389 PMID: 34282141
- 5. Wang Y et al.. 2024. Biomolecular condensates mediate bending and scission of endosome membranes.. Nature 634(8036):1204-1210 PMID: 39385023
- 6. Morita E et al.. 2004. Retrovirus budding.. Annu Rev Cell Dev Biol 20:395-425 PMID: 15473846
- 7. Carosi JM et al.. 2023. Receptor Recycling by Retromer.. Mol Cell Biol 43(7):317-334 PMID: 37350516
- 8. Posor Y et al.. 2015. Phosphoinositides in endocytosis.. Biochim Biophys Acta 1851(6):794-804 PMID: 25264171
